| 发明名称 |
Oral formulation for the treatment of cardiovascular diseases |
| 摘要 |
The present invention relates to a pharmaceutical composition which includes a HMG-CoA reductase inhibitor, in particular, a statin and acetylsalicylic acid in a manner to minimize interaction of acetylsalicylic acid with the statin, for use in the prevention or treatment of cardiovascular diseases. |
| 申请公布号 |
EP2810644(A1) |
申请公布日期 |
2014.12.10 |
| 申请号 |
EP20130170909 |
申请日期 |
2013.06.06 |
| 申请人 |
FERRER INTERNACIONAL, S.A.;FUNDACIÓN CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (CNIC) |
发明人 |
MARTIN SANZ, PABLO;URBANO HURTADO, JAVIER |
| 分类号 |
A61K9/50;A61K31/40;A61K31/403;A61K31/60;A61P9/00 |
主分类号 |
A61K9/50 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
